Adamis Pharmaceuticals Corp (ADMP)

[ShortsRClowns]

Links to use to compare w/ Tempol...

'Molnupiravir was generally well tolerated, with similar numbers of adverse events across all groups.'

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219109/#:~:text=Molnupiravir%20is%20the%20first%20oral%2C%20direct-acting%20antiviral%20shown,and%20has%20a%20favorable%20safety%20and%20tolerability%20profile.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277160/